Skip to main content

Table 2 Patient characteristics

From: MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)

Parameter

A-allele

n = 17

C-allele

n = 39

p value

Age

62 ± 14

62.4 ± 11

0.9

Gender (%male)

12 (70%)

23 (58.9%)

0.41

Smoker

13 (76.4%)

20 (51.2%)

0.08

Rapidly progressing diseasea

6 (35.2%)

8 (20.5%)

0.24

FVC %

59 ± 14.5

70 ± 19

0.02

DLCO %

46.2 ± 17

48.6 ± 17

0.66

BMI

27.6 ± 5

28.4 ± 4.5

0.61

IHD

5 (29.4%)

7 (17.9%)

0.34

CHF

1 (5.9%)

2 (5.1%)

0.9

Diabetes

7 (41.2%)

16 (41%)

1

Anxiety

1 (5.9%)

6 (15.4%)

0.3

Hypertension

6 (35.2%)

11 (28.2%)

0.64

Osteoporosis

4 (23.5%)

7 (17.9%)

0.63

Malignancy

1 (5.9%)

5 (12.8%)

0.44

  1. BMI body mass index, CHF Congestive Heart Failure, DLCO diffusing capacity for carbon monoxide, FVC forced vital capacity, IHD Ischemic heart disease
  2. aA fall in %FVC of over 10% per year was defined as rapidly progressing